VedaBio Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 29

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $28M

  • Investors
  • 7

VedaBio General Information

Description

Developer of molecular diagnostics equipment designed to bring PCR (polymerase chain reaction) accuracy at point-of-care in antigen testing times and costs. The company's platform for near-instant molecular detection of highly multiplexed analytes, delivers best-in-class accuracy without the need for target amplification, enabling medical researchers to simplify and streamline complex testing processes in a reliable and cost-effective manner.

Contact Information

Website
www.vedabio.com
Formerly Known As
LabSimply
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 11125 Flintkote Avenue
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858)
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 11125 Flintkote Avenue
  • Suite A
  • San Diego, CA 92121
  • United States
+1 (858)

VedaBio Timeline

202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VedaBio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series A) 17-Oct-2023 $28M Completed Generating Revenue
3. Early Stage VC (Series A) 31-Aug-2021 Completed Generating Revenue
2. Angel (individual) 01-Jan-2021 $125K $125K Completed Startup
1. Accelerator/Incubator Completed Startup
To view VedaBio’s complete valuation and funding history, request access »

VedaBio Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A
Series A-4
Series A-3
Series A-2 268,226 $0.000100 $2.05 $2.05 1x $2.05 5.74%
Series A-1 170,687 $0.000100 $0.73 $0.73 1x $0.73 3.65%
To view VedaBio’s complete cap table history, request access »

VedaBio Patents

  • 46

    Total Documents Applications and Grants

  • Total Patents Families

  • 36

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

VedaBio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240287623-A1 Signal boost assay performed in droplets Pending 28-Feb-2023
US-20240254463-A1 Engineered stable nucleic acid-guided nucleases Inactive 01-Feb-2023
US-12060602-B2 Sample splitting for multiplexed detection of nucleic acids without amplification Active 10-Jan-2023
US-20240240238-A1 Sample splitting for multiplexed detection of nucleic acids without amplification Active 10-Jan-2023
US-20240228993-A1 Engineered nucleic acid-guided nucleases Active 07-Jan-2023 C12Q1/44
To view VedaBio’s complete patent history, request access »

VedaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VedaBio Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Illinois Ventures Venture Capital Minority
OMX Ventures Venture Capital Minority
Fox Ventures Corporate Venture Capital Minority
Kleinmuntz Associates Venture Capital Minority
Tao Capital Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Ready to get started?

Request a free trial

VedaBio FAQs

  • When was VedaBio founded?

    VedaBio was founded in 2021.

  • Where is VedaBio headquartered?

    VedaBio is headquartered in San Diego, CA.

  • What is the size of VedaBio?

    VedaBio has 29 total employees.

  • What industry is VedaBio in?

    VedaBio’s primary industry is Diagnostic Equipment.

  • Is VedaBio a private or public company?

    VedaBio is a Private company.

  • What is the current valuation of VedaBio?

    The current valuation of VedaBio is .

  • What is VedaBio’s current revenue?

    The current revenue for VedaBio is .

  • How much funding has VedaBio raised over time?

    VedaBio has raised $29.3M.

  • Who are VedaBio’s investors?

    Illinois Ventures, OMX Ventures, Fox Ventures, Kleinmuntz Associates, and Tao Capital Partners are 5 of 7 investors who have invested in VedaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »